InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (4 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
4
T+90 hit rate
67%
T+90 mean return
+44.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Black Jeffrey G., Chief Financial Officer. Director active across 4 companies, notably EXAGEN INC.. Aggregated, 19 disclosures have been logged. Breakdown: 5 buys · 4 sells. Total volume traded: €953k. History available since 11 August 2021. The latest transaction was disclosed on 24 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations19 total
1,584 shares@ US$3.611.4% of flowCommon StockSEC:0001449439-26-000003
1,584 shares@ US$3.610.0055% mcap1.4% of flowCommon StockSEC:0001449439-26-000003:0
20,466 shares@ US$9.7948.6% of flowCommon StockSEC:0001628280-25-041688
20,466 shares@ US$9.790.20% mcap48.6% of flowCommon StockSEC:0001628280-25-041688:0
15,000 shares0Common StockSEC:0001274737-25-000011:0
22,298 shares@ US$2.9815.1% of flowCommon StockSEC:0001274737-24-000096:0
Ideal exit: 12 Aug 2025 (T+270)
6,690 shares@ US$1.9111.4% of flowCommon StockSEC:0000950170-24-104133:0
225,000 shares0Common StockSEC:0001274737-24-000084:0
13,157 shares0Common StockSEC:0000950170-24-098700:0
300,000 shares0Common StockSEC:0000950170-24-063094:0
52,631 shares0Common StockSEC:0000950170-24-061315:0
43,492 shares@ US$2.215788.6% of flowCommon StockSEC:0001162194-23-000030:0
Ideal exit: 12 Feb 2024 (T+270)
335,330 sharesCommon StockSEC:0001251769-23-000022:0
15,060 shares@ US$6.4617.1% of flowCommon StockSEC:0001251769-22-000085:0
6,190 shares@ US$6.466.7% of flowCommon StockSEC:0001251769-22-000074:0
88,900 shares0Common StockSEC:0001251769-22-000055:0
15,000 shares@ US$5.4816.5% of flowCommon StockSEC:0001251769-22-000020:0
Ideal exit: 22 Nov 2022 (T+270)
25,000 shares@ US$8.7541.8% of flowCommon StockSEC:0001251769-21-000103:0
Ideal exit: 8 May 2022 (T+270)
25,000 shares@ US$8.7531.9% of flowCommon StockSEC:0001251769-21-000103
Ideal exit: 8 May 2022 (T+270)
19 of 19 declarations
About Black Jeffrey G.
Jeffrey G. Black is the Chief Financial Officer of Exagen Inc. and Apollo Endosurgery, Inc. He is responsible for the financial management of these companies, including budget planning and financial performance analysis. His role is essential in ensuring the profitability and growth of these organizations. Jeffrey works closely with other executives to align financial and strategic objectives.
